Genetic polymorphisms in patients with myelodysplastic syndrome

Acta Microbiologica et Immunologica Hungarica

Volumn 52, Issue 3-4, 2005, Pages 463-475

  Gyulai, Zsófia ^a   Balog, A ^a   Borbényi, Zita ^a   Mándi, Yvette ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Gene polymorphism; Myelodysplastic syndrome; Transforming growth factor beta; Tumor necrosis factor alfa

Indexed keywords

EID: 29144486826     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.52.2005.3-4.15     Document Type: Article

References (36)

1. Hellström-Lindberg, E., Willman, C., Barrett, A. J., Saunthararajah, Y.: Achievements in understanding and treatment of myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 110-132 (2000).
2. Greenberg, P. L., Young, N. S., Gattermann, N.: Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 136-161 (2002).
3. Gersuk, G. M., Beckham, C., Loken, M. R., Kiener, P., Anderson, J. E., Farrand, A., Troutt, A. B., Ledbetter, J. A., Deeg, H. J.: A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 103, 176-188 (1998).
4. Raza, A., Gezer, S., Mundle, S., Gao, X. Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A.: Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86, 268-276 (1995).
5. Moldoveanu, E., Moicean, A., Vidulescu, C., Marta, D., Colita, A.: Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic: cytokines. J Cell Mol Med 7, 313-321 (2003).
6. Kiss, C., Benko, I., Kovacs, P.: Leukemic cells and the cytokine patchwork. Pediatr Blood Cancer 42, 113-121 (2004).
7. Molnar, L., Berki, T., Hussain, A., Nemeth, P., Losonczy, H.: Detection of TNFα expression in the bone marrow and determination of TNFa production of peripheral blood mononuclear cells in myelodysplastic syndrome. Pathol Oncol Res 6, 18-23 (2000).
8. Blobe, G. C., Schiemann, W. P., Lodish, H. F.: Role of transforming growth factor beta in human disease. N Engl J Med 342, 1350-1358 (2000).
9. Bruno, E., Horrigan, S. K., Van Den Berg, D., Rozler, E., Fitting, P. R., Moss, S. T., Westbrook, C., Hoffman, R.: The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 91, 1917-1923 (1998).
10. Allampallam, K., Shetty, V., Mundle, S., Dutt, D., Kravitz, H., Reddy, P. L., Alvi, S., Galili, N., Saberwal, G. S., Anthwal, S., Shaikh, M. W., York, A., Raza, A.: Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. Int J Hematol 75, 289-297 (2002).
11. Maciejewski, J. P., Risitano, A. M., Sloand, E. M., Wisch, L., Geller, N., Barrett, J. A., Young, N. S., Ristiano, A. M.: A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. Br J Haematol 117, 119-126 (2002).
12. Greenberg, P.: Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. Ann Rheum Dis 60 Suppl 3), iii 41-42 (2001).
13. Hofmann, W. K., Seipelt, G., Ottmann, O. G., Kalina, U., Koschmieder, S., Brucher, J., Frickhofen, N., Klausmann, M., Mitrou, P. S., Hoelzer, D.: Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. Ann Hematol 79, 255-258 (2000).
14. Wilson, A. G., di Giovine, F. S., Blakemore, A. I., Duff, G. W.: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1, 353 (1992).
15. Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., Duff, G. W.: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94, 3195-3199 (1997).
16. Bouma, G., Crusius, J. B., Oudkerk Pool, M., Kolkman, J. J., von Blomberg, B. M., Kostense, P. J., Giphart, M. J., Schreuder, G. M., Meuwissen, S. G., Pena, A. S.: Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43, 456-463 (1996).
17. Wood, N. A., Thomson, S. C., Smith, R. M., Bidwell, J. L.: Identification of human TGF-beta1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 234, 117-122 (2000).
18. Awad, M. R., El-Gamel, A., Hasleton, P., Turner, D. M., Sinnott, P. J., Hutchinson, I. V.: Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66, 1014-1020 (1998).
19. Arkwright, P. D., Laurie, S., Super, M., Pravica, V., Schwarz, M. J., Webb, A. K., Hutchinson, I. V.: TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55, 459-462 (2000).
20. Hinke, V., Seck, T., Clanget, C., Scheidt-Nave, C., Ziegler, R., Pfeilschifter, J.: Association of transforming growth factor-beta1 (TGFbeta1) T29 -> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal German women. Calcified Tissue Intern 69, 315-320 (2001).
21. Turner, D., Grant, S. C., Yonan, N., Sheldon, S., Dyer, P. A., Sinnott, P. J., Hutchinson, I. V.: Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779 (1997).
22. Azzawi, M., Hasleton, P. S., Turner, D. M., Yonan, N., Deiraniya, A. K., Sinnott, P. J., Hutchinson, I. V.: Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol 62, 140-142 (2001).
23. Bathgate, A. J., Pravica, V., Perrey, C., Therapondos, G., Plevris, J. N., Hayes, P. C., Hutchinson, I. V.: The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 69, 1514-1517 (2000).
24. Nadel, S., Newport, M. J., Booy, R., Levin, M.: Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174, 878-880 (1996).
25. Tang, G. J., Huang, S. L., Yien, H. W., Chen, W. S., Chi, C. W., Wu, C. W., Lui, W. Y., Chiu, J. H., Lee, T. Y.: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 28, 2733-2736 (2000).
26. Warle, M. C., Farhan, A., Metselaar, H. J., Hop, W. C., Perrey, C., Zondervan, P. E., Kap, M., de Rave, S., Kwekkeboom, J., Ijzermans, J. N., Tilanus, H. W., Pravica, V., Hutchinson, I. V., Bouma, G. J.: Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl 8, 603-611 (2002).
27. Xaubet, A., Marin-Arguedas, A., Lario, S., Ancochea, J., Morell, F., Ruiz-Manzano, J., Rodriguez-Becerra, E., Rodriguez-Arias, J. M., Inigo, P., Sanz, S., Campistol, J. M., Mullol, J., Picado, C.: Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168, 431-435 (2003).
28. Holweg, C. T., Baan, C. C., Niesters, H. G., Vantrimpont, P. J., Mulder, P. G., Maat, A. P., Weimar, W., Balk, A. H.: TGF-beta1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant 20, 979-984 (2001).
29. Clancy, R. M., Backer, C. B., Yin, X., Kapur, R. P., Molad, Y., Buyon, J. P.: Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 171, 3253-3261 (2003).
30. Rosenfeld, C., List, A.: A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia 14, 2-8 (2000).
31. Perrey, C., Turner, S. J., Pravica, V., Howell, W. M., Hutchinson, I. V.: ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transplant Immunology 7, 127-128 (1999).
32. McGuire, W., Knight, J. C., Hill, A. V., Allsopp, C. E., Greenwood, B. M., Kwiatkowski, D.: Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Inf Dis 179, 287-290 (1999).
33. Roodman, G. D., Bird, A., Hutzler, D., Montgomery, W.: Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Haematol 15, 928-935 (1987).
34. Gersuk, G. M., Beckham, C., Loken, M. R., Kiener, P., Anderson, J. E., Farrand, A., Troutt, A. B., Ledbetter, J. A., Deeg, H. J.: A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 103, 176-188 (1998).
35. Stoll, C., Mengsteab, S., Stoll, D., Riediger, D., Gressner, A. M., Weiskirchen, R.: Analysis of polymorphic: TGFBI codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults. BMC Medical Genetics 5, 15 (2004).
36. Yokota, M., Ichihara, S., Lin, T. L., Nakashima, N., Yamada, Y.: Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101, 2783-2787 (2000).